![]()
MIRA INFORM REPORT
|
Report Date : |
21.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
PDM PHARMATEC INC. |
|
|
|
|
Registered Office : |
225 34th St Ste 1505, New York,
Ny 10122 |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
24.11.1997 |
|
|
|
|
Legal Form : |
Corporation for profit |
|
|
|
|
Line of Business : |
Wholesale Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 40,000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
United States |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Comments on the rating: A Credit line maybe considered
|
POLITICAL DATA |
ECONOMIC DATA |
|
Form of Government: Federal
|
Currency: USD |
|
Ordered as: |
PDM Pharmatec Inc |
||
|
Address in the order: |
225 West 34th Street Suite 2103 New York, NY 10122 |
||
|
|
|
||
|
Legal Name: |
PDM PHARMATEC INC. |
||
|
|
|
||
|
Legal Address |
225 34TH ST STE 1505, NEW YORK, NY 10122, USA |
||
|
|
|
||
|
Telephone: |
(212) 736-6544 |
ID Number : |
2202057 |
|
Fax: |
(212) 736-6542 |
Legal Form: |
Corporation for profit |
|
Email: |
NA |
Registered in: |
New York |
|
Website: |
NA |
Date Created: |
NA |
|
Manager: |
Dusko Plavec President |
Date Incorporated: |
November 24, 1997 |
|
Staff: |
4 |
Stock: |
NA |
|
|
|
Value: |
NA |
|
Activity: |
Wholesale Pharmaceutical Products |
||
|
Name of the Bank |
Bank of America |
|
HISTORY |
|
|
|
It was established in 1997 and incorporated in New York. |
|
PRINCIPAL ACTIVITY |
|
|
|
Wholesale Pharmaceutical Products. This is a small but established company. The structure is believed to have international business partners. |
|
The subject employs 4 employee(s) |
|
|
PAYMENTS |
|
|
|
regular |
|
Comments on location: |
|
|
|
Single location |
|
Shareholders Parent Company(ies): |
|
|
|
Plavec Family is believed to be the main shareholder. |
|
Management: |
|
|
|
President Dusko Plavec Vice President Mirjana Plavec |
|
As a private company the subject does not publish any financial
statements. |
|
However our financial sources could provide us with the following
data. Those figures are estimates provided by confidential banking and
financial institutions working with the company. |
|
Currency |
DATE |
|
USD |
2010 |
|
Turnover |
$2.5 to 5 million |
|
Legal Fillings |
|
There are no UCC** files listed with the
Secretary of State of New York. There are no legal filings listed with the
District Court. The last annual report was filed on 2010. THE COMPANY IS NOT LISTED ON THE OFAC
LIST.* For information: * The Specially Designated Nationals (SDN)
List is a publication of OFAC which lists individuals and organizations with
whom United States citizens and permanent residents are prohibited from doing
business. ** The Uniform Commercial Code (UCC) is
one of a number of uniform acts that have been promulgated in conjunction
with efforts to harmonize the law of sales and other commercial transactions
in all 50 states within the United States of America. The UCC deals primarily with transactions
involving personal property (movable property), not real property (immovable
property). It allows a creditor to notify other
creditors about a debtor’s assets used as collateral for a secured
transaction by filing a public notice (financing statement) with a particular
filing office. The Uniform Commercial Code Bureau files
and maintains on financial obligations (including IRS liens) incurred by individuals
(in business as a sole proprietor), business entities and corporations. |
|
Local credit bureau gave a correct credit
rate. The company is in Good Standing. This
means that all local and federal taxes were paid on due date. |
|
|
Final
Opinion |
|
|
|
This is a small size business with 4
employees. The company’s turnover can be considered
fair for the company’s size. We did not find any specific adverse
record against the company during the investigation. A credit line may be considered for USD
40,000 |
|
|
|
||
|
Profitability |
CORRECT |
Public Records |
NO |
|
Indebtedness |
CONTROLLED |
Payments |
REGULAR |
|
Cash |
NORMAL |
|
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.46 |
|
UK Pound |
1 |
Rs.71.67 |
|
Euro |
1 |
Rs.62.94 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.